KRAS and colorectal carcinoma: In contrast, SLC25A21 expression was significantly reduced in KRAS-mutant CRC tissues based on IHC staining, while patients with lower SLC25A21 expression exhibited poorer survival outcomes, particularly in KRAS-mutant CRC cases [217].